Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01191060
Show Display Options
Rank Status Study
1 Active, not recruiting Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years
Condition: Myeloma
Intervention: Drug: Lenalidomide, Bortezomib

Study has passed its completion date and status has not been verified in more than two years.